Company registration number: 13140422
Annual report and unaudited financial statements
for the year ended 31 December 2025
for
Scholars Therapies Ltd
Pages for filing with the Registrar
Company registration number: 13140422
Scholars Therapies Ltd
Balance sheet
as at 31 December 2025
2025 2024
Note £ £ £ £
Fixed assets
Tangible assets 4 1,259 1,679
1,259 1,679
Current assets
Debtors 719 3,500
Cash at bank and in hand 35,778 14,238
36,497 17,738
Creditors: amounts falling due within one year
(395) (1,976)
Net current assets 36,102 15,762
Total assets less current liabilities 37,361 17,441
Creditors: Amounts falling due after more than one year
(36,884) (16,743)
NET ASSETS 477 698
Capital and reserves
Called up share capital 1 1
Profit and loss account 476 697
TOTAL EQUITY 477 698
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 December 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 13140422
Scholars Therapies Ltd
Balance sheet - continued
as at 31 December 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
Signed by:
Mr G Rhys Thomas, Director
8 September 2026
2
Scholars Therapies Ltd
Notes to the financial statements
for the year ended 31 December 2025
1 Company information
Scholars Therapies Ltd is a private company registered in England and Wales. Its registered number is 13140422. The company is limited by shares. Its registered office is 18 Navenby Road, Wigan, Wigan, WN3 5QJ.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the director has assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company’s ability to continue as a going concern. In making this assessment, the director takes into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The director considers that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
TOOLS & EQUIPMENTS - 20% straight line
Taxation
Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
3 Average number of employees
During the year the average number of employees was 2 (2024 - 2).
3
Scholars Therapies Ltd
Notes to the financial statements - continued
for the year ended 31 December 2025
4 Tangible fixed assets
Plant and machinery etc.

£
Cost
At 1 January 2025 2,099
At 31 December 2025 2,099
Depreciation
At 1 January 2025 420
Charge for year 420
At 31 December 2025 840
Net book value
At 31 December 2025 1,259
At 31 December 2024 1,679
Cost or valuation at 31 December 2025 is represented by:
Plant and machinery etc.

£
Valuation in 2024 2,099
Cost -
2,099
If Plant and Machinery had not been revalued, Nil would have been included at the following historical cost:
2025 2024
£ £
Cost 1,259 2,099
Accumulated depreciation 840 420
4
Scholars Therapies Ltd
Notes to the financial statements - continued
for the year ended 31 December 2025
5 Advances, credit and guarantees granted to the director
The following advances and credits to directors subsisted during the years ended 31 December 2025 and 31 December 2024.
2025 2024
£ £
Amounts advanced - (3,500)
Balance outstanding at end of year - (3,500)
2025 2024
£ £
Mr Gareth Rhys Thomas
Balance outstanding at start of year (3,500) -
Amounts advanced 3,500 -
Balance outstanding at end of year - -
5